SMTL ID : 3zc6.4 (3 other biounits)

Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.42 Å

Oligo State

monomer

Ligands

1 x VFC: N-[(2R)-1-(3-CYANOAZETIDIN-1-YL)-1-OXIDANYLIDENE-PROPAN-2-YL]-2-(6-FLUORANYL-1-METHYL-INDAZOL-3-YL)-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXAMIDE(Non-covalent)

VFC.1: 21 residues within 4Å: Chain A: L.16, G.17, K.18, G.19, G.22, S.23, V.24, A.41, K.43, V.72, M.90, E.91, Y.92, L.93, G.96, C.97, R.99, D.100, N.142, L.144, D.155 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.16, A:V.24, A:L.144 Hydrogen bonds: A:L.93 Halogen bonds: A:R.99

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 2 residues within 4Å: Chain A: A.38, L.39 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lynch, S.M. et al., Strategic Use of Conformational Bias and Structure Based Design to Identify Potent Jak3 Inhibitors with Improved Selectivity Against the Jak Family and the Kinome. Bioorg.Med.Chem.Lett. (2013)

Release Date

2013-09-25

Peptides

TYROSINE-PROTEIN KINASE JAK3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

TYROSINE-PROTEIN KINASE JAK3

Related Entries With Identical Sequence